S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 11, 2013, Pages 1495-1508

  Jia, W ^a   Gao, X J ^b   Zhang, Z D ^b   Yang, Z X ^b   Zhang, G ^b  

^a SICHUAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Metastasis; S100A4; Thyroid cancer

Indexed keywords

CALVASCULIN; COMPLEMENTARY DNA; GELATINASE B; SMALL INTERFERING RNA; VASCULOTROPIN; PROTEIN S 100; S100A4 PROTEIN, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CELLS; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; THYROID CANCER; TUMOR INVASION; APOPTOSIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; THYROID TUMOR; TUMOR CELL LINE; VASCULARIZATION;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING; S100 PROTEINS; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883483164     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. GARRETT SC, VARNEY KM, WEBER DJ, BRESNICK AR. S100A4, a mediator of metastasis. J Biol Chem 2006; 281: 677-680.
2. MAZZUCCHELLI L. Protein S100A4: too long overlooked by pathologists?Am J Pathol 2002; 160: 7-13. (Pubitemid 34052259)
3. MARENHOLZ I, LOVERING RC, HEIZMANN CW. An update of the S100 nomenclature. Biochim Biophys Acta 2006; 1763: 1282-1283. (Pubitemid 44779852)
4. DONATO R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 60: 540-551.
5. DAVIES BR, DAVIES MP, GIBBS FE, BARRACLOUGH R, RUDLAND PS. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calciumbinding protein, but not with the oncogene EJ-ras-1. Oncogene 1993; 8: 999-1008. (Pubitemid 23087433)
6. GRIGORIAN M, AMBARTSUMIAN N, LYKKESFELDT AE, BASTHOLM L, ELLING F, GEORGIEV G, LUKANIDIN E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer 1996; 67: 831-841. (Pubitemid 26348813)
7. MAELANDSMO GM, HOVIG E, SKREDE M, ENGEBRAATEN O, FLORENES VA, MYKLEBOST O, GRIGORIAN M, LUKANIDIN E, SCANLON KJ, FODSTAD O. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 1996; 56: 5490-5498. (Pubitemid 27011385)
8. TAKENAGA K, NAKAMURA Y, SAKIYAMA S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 1997; 14: 331-337. (Pubitemid 27073088)
9. LEVETT D, FLECKNELL PA, RUDLAND PS, BARRACLOUGH R, NEAL DE, MELLON JK, DAVIES BR. Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer. Am J Pathol 2002; 160: 693-700. (Pubitemid 34160347)
10. ZHANG K, ZHANG M, ZHAO H, YAN B, ZHANG D, LIANG J. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway. Dis Esophagus 2012; 25: 731-739.
11. CHEN D, ZHENG XF, YANG ZY, LIU DX, ZHANG GY, JIAO XL, ZHAO H. S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.World J Gastroenterol 2012; 18: 915-922.
12. ZHANG G, LI M, JIN J, BAI Y, YANG C. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. Asian Pac J Cancer Prev 2011; 12: 2075-2080.
13. MA X, YANG Y, WANG Y, AN G, LV G. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. Cancer Lett 2010; 299: 171-181.
14. HUA J, CHEN D, FU H, ZHANG R, SHEN W, LIU S, SUN K, SUN X. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo. Cancer Lett 2010; 292: 41-47.
15. STEIN U, ARLT F, WALTHER W, SMITH J, WALDMAN T, HARRIS ED, MERTINS SD, HEIZMANN CW, ALLARD D, BIRCHMEIER W, SCHLAG PM, SHOEMAKER RH. The metastasisassociated gene S100A4 is a novel target of betacatenin/ T-cell factor signaling in colon cancer. Gastroenterology 2006; 131: 1486-1500. (Pubitemid 44708942)
16. KANG YG, JUNG CK, LEE A, KANG WK, OH ST, KANG CS. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer. Surg Oncol 2012; 105: 119-124.
17. WANG YY, YE ZY, ZHAO ZS, TAO HQ, CHU YQ. Highlevel expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 2010; 17: 89-97.
18. IKENAGA N, OHUCHIDA K, MIZUMOTO K, YU J, FUJITA H, NAKATA K, UEDA J, SATO N, NAGAI E, TANAKA M. S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg 2009; 13: 1852-1858.
19. TSUNA M, KAGEYAMA S, FUKUOKA J, KITANO H, DOKI Y, TEZUKA H, YASUDA H. Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma. Anticancer Res 2009; 29: 2547-2554.
20. DE SILVA RUDLAND S, MARTIN L, ROSHANLALL C, WINSTANLEY J, LEINSTER S, PLATT-HIGGINS A, CARROLL J, WEST C, BARRACLOUGH R, RUDLAND P. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res 2006; 12: 1192-1200. (Pubitemid 43342508)
21. SALEEM M, KWEON MH, JOHNSON JJ, ADHAMI VM, ELCHEVA I, KHAN N, BIN HAFEEZ B, BHAT KM, SARFARAZ S, REAGAN-SHAW S, SPIEGELMAN VS, SETALURI V, MUKHTAR H. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 2006; 103: 14825-14830. (Pubitemid 44527813)
22. ZHANG HY, ZHENG XZ, WANG XH, XUAN XY, WANG F, LI SS. S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity. Mol Biol Rep 2012; 39: 199-208.
23. SCHMIDT-HANSEN B, ORNAS D, GRIGORIAN M, KLINGELHOFER J, TULCHINSKY E, LUKANIDIN E, AMBARTSUMIAN N. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004; 23: 5487-5495. (Pubitemid 39044059)
24. PATEL KN, SINGH B. Genetic considerations in thyroid cancer. Cancer Control 2006; 13: 111-118.
25. GOEPFERT H, CALLENDER DL. Differentiated thyroid cancer - papillary and follicular carcinomas. Am J Otolaryngol 1994; 15: 167-179.
26. MACKENZIE EJ, MORTIMER RH. Thyroid nodules and thyroid cancer. Med J Aust 2004; 180: 242-24 7.
27. COTTERILL SJ, PEARCE MS, PARKER L.Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident? Eur J Cancer 2001; 37: 1020-1026. (Pubitemid 32397688)
28. SEGAL K, SHPITZER T, HAZAN A, BACHAR G, MARSHAK G, POPOVTZER A. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome. Otolaryngol Head Neck Surg 2006; 134: 819-822.
29. ZOU M, AL-BARADIE RS, AL-HINDI H, FARID NR, SHI Y. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Cancer 2005; 93: 1277-1284. (Pubitemid 41679414)
30. ITO Y, YOSHIDA H, TOMODA C, URUNO T, MIYA A, KOBAYASHI K, MATSUZUKA F, KAKUDO K, KUMA K, MIYAUCHI A. S100A4 expression is an early event of papillary carcinoma of the thyroid. Oncology 2004; 67: 397-402.
31. ZOU M, FAMULSKI KS, PARHAR RS, BAITEI E, AL-MOHANNA FA, FARID NR, SHI Y. Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma. J Clin Endocrinol Metab 2004; 89: 6146-6154. (Pubitemid 39628427)
32. MIN HS, CHOE G, KIM SW, PARK YJ, PARK DO J, YOUN YK, PARK SH, CHO BY, PARK SY. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid. Mod Pathol 2008; 21: 748-755. (Pubitemid 351744841)
33. SHI Y, ZOU M, COLLISON K, BAITEI EY, AL-MAKHALAFI Z, FARID NR, AL-MOHANNA FA. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model. J Clin Endocrinol Metab 2006; 91: 2373-2379. (Pubitemid 43855030)
34. CARMELIET P, JAIN RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
35. AKSLEN LA, LIVOLSI VA. Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance. Hum Pathol 2000; 31: 439-442. (Pubitemid 30262865)
36. LIN JD, CHAO TC. Vascular endothelial growth factor in thyroid cancers. Cancer Biother Radiopharm 2005; 20: 648-661.
37. YANG H, ZHAO K, YU Q, WANG X, SONG Y, LI R. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. J Int Med Res 2012; 40: 475-485.
38. FENG LZ, ZHENG XY, ZHOU LX, FU B, YU YW, LU SC, CAO NS. Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma. J Int Med Res 2011; 39: 1333-1343.
39. AI KX, LU LY, HUANG XY, CHEN W, ZHANG HZ. Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer.World J Gastroenterol 2008; 14: 1931-1937.
40. WANG Z, BANERJEE S, KONG D, LI Y, SARKAR FH. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 2007; 67: 8293-8300. (Pubitemid 47395167)
41. RUDLAND PS, PLATT-HIGGINS A, RENSHAW C, WEST CR, WINSTANLEY JH, ROBERTSON L, BARRACLOUGH R. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000; 60: 1595-1603. (Pubitemid 30183430)
42. BJØRNLAND K, WINBERG JO, ODEGAARD OT, HOVIG E, LOENNECHEN T, AASEN AO, FODSTAD O, MAELANDSMO GM. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999; 59: 4702-4708. (Pubitemid 29428979)
43. SALEEM M, KWEON MH, JOHNSON JJ, ADHAMI VM, ELCHEVA I, KHAN N, BIN HAFEEZ B, BHAT KM, SARFARAZ S, REAGAN-SHAW S, SPIEGELMAN VS, SETALURI V, MUKHTAR H. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 2006; 103: 14825-14830. (Pubitemid 44527813)
44. BOYE K, GROTTEROD I, AASHEIM HC, HOVIG E, MAELANDSMO GM. Activation of NF-kB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes. Int J Cancer 2008; 123: 1301-1310.
45. DE SILVA RUDLAND S, MARTIN L, ROSHANLALL C, WINSTANLEY J, LEINSTER S, PLATT-HIGGINS A, CARROLL J, WEST C, BARRACLOUGH R, RUDLAND P. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res 2006; 12: 1192-1200. (Pubitemid 43342508)
46. AMBARTSUMIAN N, KLINGELHOFER J, GRIGORIAN M, CHRISTENSEN C, KRIAJEVSKA M, TULCHINSKY E, GEORGIEV G, BEREZIN V, BOCK E, RYGAARD J, CAO R, CAO Y, LUKANIDIN E. The metastasis-associated Mts1 (S100A4) protein could act as an angiogenic factor. Oncogene 2001; 20: 4685-4695. (Pubitemid 32762440)
47. SCHMIDT-HANSEN B, ORNAS D, GRIGORIAN M, KLINGELHOFER J, TULCHINSKY E, LUKANIDIN E, AMBARTSUMIAN N. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004; 23: 5487-5495. (Pubitemid 39044059)
48. SEMOV A, MORENO MJ, ONICHTCHENKO A, ABULROB A, BALL M, EKIEL I, PIETRZYNSKI G, STANIMIROVIC D, ALAKHOV V. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005; 280: 20833-20841. (Pubitemid 40776788)
49. HUA J, CHEN D, FU H, ZHANG R, SHEN W, LIU S, SUN K, SUN X. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo. Cancer Lett 2010; 292: 41-47.
50. TABATA T, TSUKAMOTO N, FOOLADI AA, YAMANAKA S, FURUKAWA T, ISHIDA M, SATO D, GU Z, NAGASE H, EGAWA S, SUNAMURA M, HORII A. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun 2009; 390: 475-80.
51. GRIGORIAN M, ANDRESEN S, TULCHINSKY E, KRIAJEVSKA M, CARLBERG C, KRUSE C, COHN M, AMBARTSUMIAN N, CHRISTENSEN A, SELIVANOVA G, LUKANIDIN E. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001; 276: 22699-22708.